ArticleBMJ open2026

Reducing severe breathlessness with dronabinol in the group of patients with severe and very severe chronic obstructive pulmonary disease (BONG): a randomised, double-blinded, placebo-controlled, crossover study in an outpatient clinic in Denmark - a study protocol.

Sofie Krogh Wolsing et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.